Coronavirus disease 2019 (COVID-19) vaccines are now available to children in the U.S. Here's what parents and kids need to know about the safety and effectiveness of the vaccine, the possible side effects, and the benefits of getting vaccinated.
A COVID-19 vaccine and booster, updated to the most common strain of the virus that causes COVID-19, might prevent your child from getting the COVID-19 virus or becoming seriously ill or hospitalized due to COVID-19.
Getting a COVID-19 vaccine can help your child more safely participate in sports and other group activities too.
In the U.S., COVID-19 vaccines are available to children by age group:
Ages 6 months through 4 or 5 years old. The U.S. Food and Drug Administration (FDA) has given emergency use authorization to a Pfizer-BioNTech COVID-19 vaccine for children ages 6 months through 4 years old. This vaccine requires three shots. The first two shots are given three to eight weeks apart. The third shot is given at least eight weeks after the second shot. Research shows that the three shots have produced antibody levels similar to those in young adults after getting the Pfizer-BioNTech vaccine.
The FDA has also given emergency use authorization to a Moderna COVID-19 vaccine for children ages 6 months through 5 years old. This vaccine requires two shots, given four to eight weeks apart. It's estimated that this vaccine is about 51% effective in preventing COVID-19 in babies ages 6 months through 23 months. For kids ages 2 through 5 years old, the vaccine is estimated to be 37% effective in preventing COVID-19.
Both vaccines contain lower amounts of mRNA than the mRNA COVID-19 vaccines for older children and adults.
Ages 5 or 6 through 11. The FDA has given emergency use authorization to a Pfizer-BioNTech COVID-19 vaccine for children ages 5 through 11. This vaccine involves two shots, given three to eight weeks apart. It contains a lower amount of mRNA than the Pfizer-BioNTech COVID-19 vaccine used for people age 12 and older. Research shows that this vaccine is about 91% effective in preventing COVID-19 in this age group.
The FDA has also given emergency use authorization to a Moderna COVID-19 vaccine for children ages 6 through 11. This vaccine requires two shots, given four to eight weeks apart. For kids in this age group, the Moderna vaccine causes an immune response similar to that seen in adults.
Both vaccines contain lower amounts of mRNA than the COVID-19 vaccines for people age 12 and older.
Ages 12 through 17. The FDA has approved the Pfizer-BioNTech COVID-19 vaccine, now called Comirnaty, for people age 12 through 17. This vaccine involves three shots. The first two are given three to eight weeks apart. The third shot, a booster, is given at least two months after the second shot. It contains the same amount of mRNA as the Pfizer-BioNTech COVID-19 vaccine for people age 16 and older. Research has shown that this vaccine is 100% effective in preventing COVID-19 in children ages 12 through 15.
This vaccine is 91% effective in preventing severe illness with COVID-19 in people age 16 and older.
The FDA has also given emergency use authorization to a Moderna COVID-19 vaccine for children ages 12 through 17. This vaccine requires two shots, given four to eight weeks apart. It contains the same amount of mRNA as the Moderna COVID-19 vaccine for people age 18 and older. For kids ages 12 through 17, the Moderna COVID-19 vaccine causes an immune response similar to that seen in adults.
The FDA has also given emergency use authorization to a Novavax COVID-19 vaccine for people age 12 and older. This vaccine requires two shots, given three to eight weeks apart. Based on research submitted to the FDA, in children age 12 through 17, this vaccine is about 78% effective in preventing symptomatic COVID-19 illness.
An eight-week interval between the first and second doses might be best for some people, especially males ages 12 to 39. A longer interval might increase protection against COVID-19 and reduce the risk of rare heart problems, such as myocarditis and pericarditis.
An additional primary shot of a COVID-19 vaccine can help people who are vaccinated and might not have had a strong enough immune response. The CDC now recommends that children age 6 months to 5 years who have a weakened immune system get at additional dose of the Moderna COVID-19 vaccine at least four weeks after their second shot. Children ages 5 and older who have moderately or severely weakened immune systems should get additional doses of the Pfizer-BioNTech COVID-19 vaccine or the Moderna COVID-19 vaccine. This shot should be given at least four weeks after the second shot for kids ages 5 through 11 for the Pfizer-BioNTech COVID-19 vaccine and the Moderna COVID-19 vaccine. For kids ages 12 and older the additional shot should be given at least four weeks after the second shot for the Pfizer BioNTech COVID-19 vaccine and Moderna COVID-19 vaccine.
Booster doses can help people who are vaccinated and whose immune response weakened over time. Research suggests that getting a booster dose can decrease the risk of infection and severe illness with COVID-19.
Kids ages 5 through 17 should get a Pfizer-BioNTech COVID-19 vaccine booster shot if they have been given both doses of a Pfizer-BioNTech COVID-19 vaccine and it's been at least 2 months (age 12 to 17) or 5 months (age 5 to 11) since the second shot.
Kids ages 5 through 11 who have a weakened immune system should get a Pfizer-BioNTech COVID-19 vaccine booster shot if they have been given all recommended doses of the Pfizer-BioNTech COVID-19 vaccine and it's been at least three months since the additional primary shot.
Kids age 12 and older who have a weakened immune system, got all recommended doses of the Moderna, Pfizer-BioNTech or Novavax COVID-19 vaccine, also can get an updated booster dose of the Pfizer-BioNTech COVID-19 vaccine. The updated booster can be given at least two months after the last shot.
For kids ages 5 through 11, the FDA reviewed a vaccine study of more than 4,600 children in this age range. Of this group, about 3,100 were given the Pfizer-BioNTech COVID-19 vaccine. The other children were given an inactive (placebo) shot. Children who were given the vaccine were monitored for side effects for at least 2 months after the second dose. Side effects were generally mild to moderate.
The FDA also took an early look at cases of COVID-19 that occurred one week after children were given a second dose of the vaccine. None of the children in this analysis had been previously diagnosed with COVID-19. Among 1,305 children given the vaccine, there were 3 cases of COVID-19. Among 663 children given the placebo, there were 16 cases of COVID-19. The results suggest that the vaccine is about 91% effective in preventing COVID-19 in this age group.
For kids ages 12 through 15, the FDA reviewed a vaccine study of more than 2,200 U.S. children in this age range. Of this group, about half were given the Pfizer-BioNTech COVID-19 vaccine. The other children were given a placebo shot.
A week after the second dose was given, there were no cases of COVID-19 in the 1,005 children given the Pfizer-BioNTech vaccine. Among 978 children given the placebo, there were 16 cases of COVID-19. None of the children had previously been diagnosed with COVID-19. The results suggest that the vaccine is 100% effective at preventing COVID-19 in this age group.
To determine the effectiveness of the Pfizer-BioNTech vaccine for kids ages 6 months through 4 and the Moderna COVID-19 vaccine for kids ages 6 months through 17 years old, the FDA looked at the immune responses of children in these age groups after they were fully vaccinated. The FDA compared those responses to the immune responses of young adults who'd been given higher doses of the same mRNA vaccine.
As with the other vaccines, side effects were recorded and a portion of the children were monitored for safety for at least two months after being fully vaccinated.
To determine the effectiveness of the Novavax COVID-19 vaccine, the FDA reviewed data on 2,232 people age 12 to 17. The research suggests that the vaccine was about 78% effective at preventing COVID-19 disease in this age group.
Children given COVID-19 vaccines had side effects similar to those experienced by adults. The most commonly reported side effects include:
Babies ages 6 months through 3 years old also might cry, feel sleepy or lose their appetite after vaccination.
Similar to adults, children have side effects within 2 days after vaccination that typically last 1 to 3 days. More children reported these side effects, except for injection site pain, after the second dose of the vaccine. However, some people have no side effects.
After your child is given a COVID-19 vaccine, he or she will be monitored for 15 to 30 minutes to see if he or she has an allergic reaction that requires treatment.
It isn't recommended that you give your child an over-the-counter pain reliever before vaccination to prevent side effects. It's OK to give this kind of medication after your child gets a COVID-19 vaccine.
In the U.S., there has been an increase in reported cases of myocarditis and pericarditis after mRNA COVID-19 vaccination, particularly in males ages 12 to 29. Myocarditis is the inflammation of the heart muscle, while pericarditis is the inflammation of the lining outside the heart. These reports are rare.
Of the cases reported, the problem happened more often after the second dose of the COVID-19 vaccine and typically within one week of COVID-19 vaccination. Most of the people who got care quickly felt better after receiving medicine and resting. Symptoms to watch for include:
If your child has any of these symptoms within a week of getting a COVID-19 vaccine, seek medical care.
If your child develops myocarditis or pericarditis after a dose of an mRNA COVID-19 vaccine, the CDC recommends avoiding getting another dose of any COVID-19 vaccine.
Because COVID-19 vaccine clinical trials only started in the summer of 2020, it's not yet clear if the vaccines will have long-term effects. However, vaccines rarely cause long-term effects.
A portion of the children in each age group were monitored for safety for at least two months after being fully vaccinated.
In addition, in the U.S. all vaccination providers are required to report serious adverse events, such as allergic reactions, to a national program called the Vaccine Adverse Event Reporting System.
The Pfizer-BioNTech and the Moderna COVID-19 vaccines use messenger RNA (mRNA). Researchers have been studying mRNA vaccines for decades.
Coronaviruses have a spikelike structure on their surface called an S protein. COVID-19 mRNA vaccines give cells instructions for how to make a harmless piece of an S protein. After vaccination, muscle cells begin making the S protein pieces and displaying them on cell surfaces. The immune system recognizes the protein and begins building an immune response and making antibodies. After delivering instructions, the mRNA is immediately broken down. It never enters the nucleus of the cell, where DNA is kept.
Yes. The Pfizer-BioNTech COVID-19 vaccine for children ages 6 months to 4 years old and the Moderna COVID-19 vaccine for children ages 6 months through 5 years contain lower amounts of mRNA than their COVID-19 vaccines for older children and adults.
The Pfizer-BioNTech COVID-19 vaccine for children ages 5 through 11 and the Moderna COVID-19 vaccine for children ages 6 through 11 also contain lower amounts of mRNA than their COVID-19 vaccines for people age 12 and older.
Smaller needles are also used to deliver the vaccine to the younger children.
COVID-19 vaccines shouldn't be given to a child with a known history of a severe allergic reaction to any of its ingredients. If this is the case, your child might be able to get another COVID-19 vaccine in the future.
No. The COVID-19 vaccines currently being developed in the U.S. don't use the live virus that causes COVID-19.
There is no evidence that any vaccines, including COVID-19 vaccines, cause fertility problems in men or women.
It's not clear if getting COVID-19 or a COVID-19 vaccine causes changes in menstruation. A new study of about 4,000 people suggests that getting a COVID-19 vaccine is linked with a less than one-day change in menstrual cycle length for each dose. Keep in mind that many things can affect menstrual cycles, including infections, stress, sleep problems, and changes in diet or exercise.
Anyone who has had COVID-19 can develop a post-COVID-19 condition. Research suggests that children with both mild and severe COVID-19 have experienced long-term symptoms. The most common symptoms in children include:
These symptoms could affect your child's ability to attend school or do his or her usual activities. If your child is experiencing long-term symptoms, consider talking to your child's teachers about his or her needs.
Consult your local health department, pharmacy or your child's doctor for information on where your child can get a COVID-19 vaccine. When making an appointment for your child to get a COVID-19 vaccine.
A COVID-19 vaccine and other vaccines can be given on the same day.
Remember, COVID-19 vaccination will protect most people from getting sick with COVID-19. If you have questions or concerns about your child getting a COVID-19 vaccine, talk to your child's doctor. He or she might be able to help you weigh the risks and benefits.
©2022 Mayo Foundation for Medical Education and Research (MRMER). All rights reserved.